New restrictions on prescribing hydroxychloroquine
The AMA is aware of reports regarding hydroxychloroquine and its inappropriate use as a therapeutic for COVID-19, and has responded quickly to this issue by working with the Department of Health and the TGA.
This medication is important for many patients, particularly those with auto-immune disorders, and it is essential that these patients continue to have a supply.
As of 24 March 2020, there are new restrictions for prescribing hydroxychloroquine. Initial treatment of hydroxychloroquine must be authorised by a medical practitioner under the following specialties:
- Intensive care medicine
- Paediatrics and child health
- Emergency medicine